Open AccessComparison of Subcutaneous and Vaginal Progesterone Used for Luteal Phase Support in Patients Undergoing Intracytoplasmic Sperm Injection Cycles
Author(s) -
Saghar Salehpour,
Nasrin Saharkhiz,
Leila Nazari,
Ali Sobhaneian,
Sedighe Hosseini
Publication year - 2021
Publication title -
jbra
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 14
eISSN - 1518-0557
pISSN - 1517-5693
DOI - 10.5935/1518-0557.20200090
Subject(s) - luteal phase , intracytoplasmic sperm injection , medicine , pregnancy , gynecology , pregnancy rate , assisted reproductive technology , obstetrics , abortion , gestation , andrology , in vitro fertilisation , follicular phase , infertility , biology , genetics
Luteal phase defect in patients undergoing assisted reproductive technology (ART) is a sign of uterine failure due to insufficient progesterone effects on the endometrium. This study aims to compare the success rate and side effects of subcutaneous progesterone and vaginal progesterone to support the luteal phase in ART cycles.